Anaergia (ANRG) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Transformation under Anaergia 2.0 and a strategic shift to a capital-light business model are yielding clear improvements in operational efficiency, capital sales, geographic expansion, strategic partnerships, and balance sheet strength.
Revenue grew 36.8% year-over-year to $32.3 million in Q2 2025, driven by higher capital sales in North America and Italy.
Gross profit margin rose to 32.5% from 17.6% year-over-year, reflecting improved margins across all segments.
Revenue backlog increased to $244 million, up 137% from year-end, indicating strong customer demand and market confidence.
Expanded agreements in Europe and North America, with repeat business from established partners, highlight growing market traction.
Financial highlights
Q2 2025 revenue was $32.3 million, up 36.8% year-over-year and 30% sequentially, driven by capital sales in North America and Italy and higher service revenues.
Gross profit reached $10.5 million, up 152.9% year-over-year, with gross margin improving to 32.5% from 17.6% in Q2 2024.
SG&A expenses decreased 3.7% to $14.3 million, reflecting ongoing cost control.
Net loss improved to $9.5 million, a 29% reduction from Q2 2024.
Adjusted EBITDA loss narrowed to $2.2 million, a 72.1% improvement year-over-year.
Outlook and guidance
Backlog as of June 30, 2025, was $244 million, up 137% from year-end, providing strong visibility into future revenue.
Additional $43.8 million in new capital sales contracts signed since quarter-end, driven by demand in Italy and North America.
Management expresses optimism for future growth, citing a robust market and regulatory tailwinds.
Focus remains on profitable growth, disciplined execution, and expanding the global project pipeline.
Latest events from Anaergia
- Capital-light shift and new leadership drove improved margins and liquidity despite lower revenue.ANRG
Q3 202413 Jan 2026 - Improved margins, major contract wins, and a $103.3M backlog set up strong 2025 growth.ANRG
Q4 202426 Dec 2025 - Backlog rose 94% to CAD 200 million, with improved margins and reduced net loss.ANRG
Q1 202526 Nov 2025 - Q3 2025 delivered 77% revenue growth, positive adjusted EBITDA, and a $287M backlog.ANRG
Q3 202517 Nov 2025 - Q2 2024 delivered higher margins and a smaller net loss despite a 45% revenue decline.ANRG
Q2 202413 Jun 2025 - 2023 saw revenue decline, deepening losses, and major restructuring with new strategic investment.ANRG
Q4 202313 Jun 2025 - Revenue declined sharply, but gross profit margin improved on stronger O&M contracts.ANRG
Q1 202413 Jun 2025